Title : Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival.

Pub. Date : 2013

PMID : 23783486






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this study was to analyze the significance of using p38 MAPK phosphorylation as a prognostic marker in high-grade glioma patients and as a therapeutic target in combination chemotherapy with vandetanib. vandetanib mitogen-activated protein kinase 14 Homo sapiens